Your browser is no longer supported. Please, upgrade your browser.
FOLD Amicus Therapeutics, Inc. weekly Stock Chart
FOLD [NASD]
Amicus Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.30 Insider Own1.10% Shs Outstand256.97M Perf Week3.99%
Market Cap3.95B Forward P/E- EPS next Y-0.72 Insider Trans-22.50% Shs Float230.00M Perf Month-4.97%
Income-325.00M PEG- EPS next Q-0.26 Inst Own- Short Float13.90% Perf Quarter27.32%
Sales208.70M P/S18.94 EPS this Y21.10% Inst Trans-0.06% Short Ratio10.63 Perf Half Y43.60%
Book/sh1.57 P/B9.62 EPS next Y32.70% ROA-38.40% Target Price18.71 Perf Year26.78%
Cash/sh1.29 P/C11.67 EPS next 5Y-1.00% ROE-64.10% 52W Range6.25 - 16.13 Perf YTD55.03%
Dividend- P/FCF- EPS past 5Y-9.90% ROI-55.10% 52W High-6.39% Beta1.29
Dividend %- Quick Ratio4.30 Sales past 5Y172.00% Gross Margin88.30% 52W Low141.60% ATR0.59
Employees584 Current Ratio4.40 Sales Q/Q77.90% Oper. Margin- RSI (14)56.43 Volatility3.61% 4.25%
OptionableYes Debt/Eq0.37 EPS Q/Q38.60% Profit Margin- Rel Volume0.57 Prev Close14.79
ShortableYes LT Debt/Eq0.37 EarningsAug 10 BMO Payout- Avg Volume3.01M Price15.10
Recom1.60 SMA200.46% SMA506.49% SMA20037.12% Volume1,722,451 Change2.10%
Jun-17-20Initiated BTIG Research Buy $19
Feb-04-20Resumed Cantor Fitzgerald Overweight $19 → $20
Nov-12-19Reiterated H.C. Wainwright Buy $18 → $20
Jun-17-19Initiated H.C. Wainwright Buy $18
Jun-05-19Reiterated Cantor Fitzgerald Overweight $20 → $19
Apr-05-19Initiated Janney Buy
Jan-30-19Initiated Cantor Fitzgerald Overweight $20
Oct-29-18Initiated Citigroup Neutral $12
Aug-17-18Downgrade Chardan Capital Markets Buy → Neutral $18 → $15
Oct-06-17Resumed Goldman Neutral
Sep-13-17Reiterated Chardan Capital Markets Buy $17.50 → $16.50
Aug-10-17Reiterated Chardan Capital Markets Buy $12.50 → $17.50
Jan-24-17Upgrade Robert W. Baird Neutral → Outperform $7 → $10
May-18-16Initiated BofA/Merrill Buy $10
Apr-14-16Initiated Robert W. Baird Neutral $9
Apr-12-16Reiterated Chardan Capital Markets Buy $10 → $15
Sep-16-15Downgrade Chardan Capital Markets Buy → Neutral $17
Jun-16-15Reiterated Chardan Capital Markets Buy $14 → $17.50
May-29-15Initiated Chardan Capital Markets Buy $14
Dec-20-12Reiterated Canaccord Genuity Buy $11 → $6
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
Jul-31-20 07:42AM  
Jul-28-20 07:00AM  
Jul-17-20 08:04AM  
07:32AM  
Jul-12-20 08:16PM  
Jun-22-20 09:23AM  
Jun-08-20 03:38AM  
Jun-06-20 11:31AM  
Jun-04-20 07:00AM  
May-21-20 02:25PM  
May-19-20 09:47AM  
May-10-20 09:50AM  
May-09-20 01:31PM  
May-08-20 11:46AM  
07:00AM  
May-07-20 09:25AM  
07:00AM  
May-06-20 07:00AM  
May-05-20 07:00AM  
Apr-30-20 12:33PM  
Apr-24-20 07:00AM  
Apr-13-20 08:42AM  
Apr-01-20 11:30AM  
Mar-28-20 08:38PM  
Mar-24-20 10:00AM  
Mar-23-20 07:00AM  
Mar-05-20 07:00AM  
Mar-04-20 07:20AM  
Mar-03-20 02:20PM  
09:38AM  
Mar-02-20 08:25AM  
07:00AM  
Feb-26-20 07:00AM  
Feb-24-20 12:30PM  
Feb-19-20 07:00AM  
Feb-17-20 07:43AM  
Feb-07-20 07:00AM  
Jan-13-20 07:00AM  
Jan-10-20 11:43AM  
Jan-09-20 07:00AM  
Jan-08-20 10:04AM  
Jan-07-20 07:00AM  
Jan-06-20 06:32PM  
Jan-03-20 09:41AM  
Jan-02-20 08:04AM  
Dec-11-19 11:30AM  
Dec-05-19 10:53PM  
Dec-04-19 09:28AM  
Nov-20-19 10:09AM  
Nov-19-19 03:03PM  
Nov-18-19 09:24AM  
Nov-12-19 09:52AM  
09:33AM  
09:25AM  
Nov-11-19 08:15AM  
07:00AM  
Nov-08-19 12:47PM  
Nov-07-19 11:41AM  
11:15AM  
10:32AM  
Nov-05-19 11:50AM  
11:24AM  
11:13AM  
09:15AM  
Nov-04-19 11:42AM  
10:30AM  
07:13AM  
Oct-30-19 07:00AM  
Oct-24-19 04:52PM  
07:00AM  
Oct-10-19 07:30AM  
Oct-03-19 08:33PM  
08:09AM  
Oct-02-19 07:00AM  
Oct-01-19 07:00AM  
Sep-07-19 09:30AM  
Sep-04-19 07:00AM  
Aug-19-19 09:35AM  
Aug-12-19 10:59AM  
Aug-10-19 01:30AM  
Aug-08-19 09:25AM  
07:00AM  
Aug-02-19 07:00AM  
Aug-01-19 10:33AM  
06:00AM  
Jul-29-19 07:00AM  
Jul-22-19 01:07PM  
Jul-04-19 01:39PM  
11:51AM  
Jul-02-19 07:30AM  
Jul-01-19 07:00AM  
Jun-19-19 09:59PM  
Jun-13-19 07:30AM  
Jun-12-19 05:49PM  
08:44AM  
Jun-07-19 09:30AM  
Jun-05-19 11:25AM  
Jun-04-19 04:01PM  
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital, University of Pennsylvania, and GlaxoSmithKline. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crowley John FChairman & CEOAug 03Option Exercise5.9620,000119,200900,368Aug 05 04:02 PM
Campbell Bradley LChief Operating OfficerAug 03Option Exercise6.0610,00060,600348,764Aug 05 04:03 PM
WHITMAN BURKE WDirectorAug 03Buy14.531,50021,79532,467Aug 05 04:05 PM
Crowley John FChairman & CEOAug 03Sale14.7839,655586,081860,713Aug 05 04:02 PM
Campbell Bradley LChief Operating OfficerAug 03Sale14.7810,000147,779338,764Aug 05 04:03 PM
Barth JayChief Medical OfficerJul 27Option Exercise6.1030,000183,000193,204Jul 29 09:41 PM
Barth JayChief Medical OfficerJul 27Sale15.0530,000451,377163,204Jul 29 09:41 PM
Rosenberg EllenChief Legal OfficerJul 16Option Exercise5.1630,000154,800225,169Jul 20 05:31 PM
Rosenberg EllenChief Legal OfficerJul 16Sale15.2630,000457,911195,169Jul 20 05:31 PM
Crowley John FChairman & CEOJul 15Option Exercise5.1320,000102,600900,368Jul 17 06:28 PM
Crowley John FChairman & CEOJul 15Sale15.5420,000310,848880,368Jul 17 06:28 PM
Barth JayChief Medical OfficerJul 10Option Exercise5.1328,843147,965192,047Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 10Sale15.6528,843451,433163,204Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 09Option Exercise10.3744,447460,867207,651Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 09Sale15.9244,447707,494163,204Jul 13 06:54 PM
Campbell Bradley LChief Operating OfficerJul 08Option Exercise6.062,50015,150341,264Jul 09 06:47 PM
Barth JayChief Medical OfficerJul 08Option Exercise10.1764,110652,165227,314Jul 09 06:51 PM
Campbell Bradley LChief Operating OfficerJul 08Sale16.012,50040,025338,764Jul 09 06:47 PM
Barth JayChief Medical OfficerJul 08Sale15.9264,1101,020,574163,204Jul 09 06:51 PM
Barth JayChief Medical OfficerJul 07Option Exercise9.89178,9881,770,220342,192Jul 09 06:51 PM
Barth JayChief Medical OfficerJul 07Sale15.90178,9882,845,945163,204Jul 09 06:51 PM
Prout SamanthaPrincipal Accounting OfficerJul 02Option Exercise10.041981,9881,733Jul 06 07:50 PM
Prout SamanthaPrincipal Accounting OfficerJul 02Sale15.801983,12817,135Jul 06 07:50 PM
Campbell Bradley LChief Operating OfficerJul 01Option Exercise6.0612,50075,750351,264Jul 06 07:47 PM
Crowley John FChairman & CEOJul 01Option Exercise5.9620,000119,200920,023Jul 06 07:45 PM
Quimi DaphneChief Financial OfficerJul 01Option Exercise2.6219,87252,054214,051Jul 06 07:38 PM
WHITMAN BURKE WDirectorJul 01Buy15.201,50022,80030,967Jul 06 07:38 PM
Campbell Bradley LChief Operating OfficerJul 01Sale15.4712,500193,384338,764Jul 06 07:47 PM
Crowley John FChairman & CEOJul 01Sale15.4839,655613,859880,368Jul 06 07:45 PM
Quimi DaphneChief Financial OfficerJul 01Sale15.476,872106,326207,179Jul 06 07:38 PM
Barth JayChief Medical OfficerJun 29Option Exercise5.1330,000153,900193,204Jul 01 07:00 PM
Barth JayChief Medical OfficerJun 29Sale15.5130,000465,195163,204Jul 01 07:00 PM
Prout SamanthaPrincipal Accounting OfficerJun 19Option Exercise10.043,36633,79520,501Jun 23 06:47 PM
Prout SamanthaPrincipal Accounting OfficerJun 19Sale15.003,36650,49017,135Jun 23 06:47 PM
Barth JayChief Medical OfficerJun 17Sale13.471,90425,639163,204Jun 17 08:33 PM
Prout SamanthaPrincipal Accounting OfficerJun 16Sale12.952,93237,95917,135Jun 17 08:25 PM
Crowley John FChairman & CEOJun 15Option Exercise5.1320,000102,600920,186Jun 17 08:26 PM
Crowley John FChairman & CEOJun 15Sale10.8820,000217,610900,186Jun 17 08:26 PM
Campbell Bradley LChief Operating OfficerJun 02Option Exercise6.062,50015,150350,353Jun 03 09:10 PM
WHITMAN BURKE WDirectorJun 02Buy12.662,00025,31123,612Jun 03 09:06 PM
Campbell Bradley LChief Operating OfficerJun 02Sale13.012,50032,525347,853Jun 03 09:10 PM
RAAB MICHAELDirectorJun 01Option Exercise2.815,00014,05020,145Jun 03 09:09 PM
Campbell Bradley LChief Operating OfficerJun 01Option Exercise6.0610,00060,600365,355Jun 03 09:10 PM
RAAB MICHAELDirectorJun 01Sale12.655,00063,26115,145Jun 03 09:09 PM
Campbell Bradley LChief Operating OfficerJun 01Sale12.6617,502221,495347,853Jun 03 09:10 PM
Crowley John FChairman & CEOJun 01Sale12.669,755123,452900,186Jun 03 09:14 PM
Campbell Bradley LChief Operating OfficerMay 26Option Exercise6.062,50015,150357,855May 28 05:20 PM
Campbell Bradley LChief Operating OfficerMay 26Sale13.012,50032,525355,355May 28 05:20 PM
Crowley John FChairman & CEOMay 15Option Exercise5.1320,000102,600959,941May 19 07:52 PM
Crowley John FChairman & CEOMay 15Sale11.4420,000228,796939,941May 19 07:52 PM
Campbell Bradley LChief Operating OfficerMay 01Option Exercise6.0610,00060,600372,858May 05 05:46 PM
Crowley John FChairman & CEOMay 01Sale11.329,755110,469939,941May 05 05:45 PM
Campbell Bradley LChief Operating OfficerMay 01Sale11.3317,503198,239355,355May 05 05:46 PM
MCGLYNN MARGARET GDirectorApr 17Option Exercise2.8110,00028,10032,064Apr 20 04:57 PM
MCGLYNN MARGARET GDirectorApr 17Sale11.0010,000110,00022,064Apr 20 04:57 PM
Crowley John FChairman & CEOApr 15Option Exercise5.1320,000102,600969,696Apr 17 07:46 PM
Crowley John FChairman & CEOApr 15Sale9.9220,000198,412949,696Apr 17 07:46 PM
Campbell Bradley LChief Operating OfficerApr 07Option Exercise6.062,50015,150365,358Apr 09 06:38 PM
Campbell Bradley LChief Operating OfficerApr 07Sale10.122,50025,300362,858Apr 09 06:38 PM
Campbell Bradley LChief Operating OfficerApr 01Option Exercise6.067,50045,450363,014Apr 03 06:40 PM
Crowley John FChairman & CEOApr 01Sale9.089,75588,608909,081Apr 03 06:43 PM
Campbell Bradley LChief Operating OfficerApr 01Sale9.0915,003136,310348,011Apr 03 06:40 PM
Crowley John FChairman & CEOMar 20Option Exercise5.1320,000102,600938,836Mar 24 06:40 PM
Crowley John FChairman & CEOMar 20Sale9.0020,000180,000918,836Mar 24 06:40 PM
Campbell Bradley LChief Operating OfficerMar 05Option Exercise5.962,50014,900358,014Mar 09 05:56 PM
Campbell Bradley LChief Operating OfficerMar 05Sale10.012,50025,025355,514Mar 09 05:56 PM
Campbell Bradley LChief Operating OfficerMar 02Option Exercise5.967,50044,700370,517Mar 04 06:53 PM
Crowley John FChairman & CEOMar 02Sale9.109,75588,745918,836Mar 04 06:54 PM
Campbell Bradley LChief Operating OfficerMar 02Sale9.0915,003136,445355,514Mar 04 06:53 PM
Crowley John FChairman & CEOFeb 18Option Exercise5.1320,000102,600948,591Feb 20 04:44 PM
Crowley John FChairman & CEOFeb 18Sale10.8320,000216,676928,591Feb 20 04:44 PM
Do HungChief Science OfficerFeb 12Option Exercise6.0853,100322,601574,255Feb 14 04:19 PM
Do HungChief Science OfficerFeb 12Sale11.0163,356697,340510,899Feb 14 04:19 PM
Campbell Bradley LChief Operating OfficerFeb 05Option Exercise5.962,50014,900365,517Feb 07 05:19 PM
Campbell Bradley LChief Operating OfficerFeb 05Sale10.012,50025,025363,017Feb 07 05:19 PM
Campbell Bradley LChief Operating OfficerFeb 03Option Exercise5.967,50044,700378,020Feb 04 05:38 PM
Crowley John FChairman & CEOFeb 03Sale8.919,75486,882928,591Feb 04 05:36 PM
Campbell Bradley LChief Operating OfficerFeb 03Sale8.9115,003133,626363,017Feb 04 05:38 PM
Crowley John FChairman & CEOJan 15Option Exercise5.1320,000102,6001,058,339Jan 17 05:37 PM
Rosenberg EllenChief Legal OfficerJan 15Sale10.3522,100228,642185,350Jan 17 05:39 PM
Campbell Bradley LChief Operating OfficerJan 15Sale10.355,06452,388370,520Jan 17 05:38 PM
Barth JayChief Medical OfficerJan 15Sale10.3520,720214,359156,473Jan 17 05:39 PM
Crowley John FChairman & CEOJan 15Sale10.35100,0001,034,790958,339Jan 17 05:37 PM
MCGLYNN MARGARET GDirectorJan 09Option Exercise3.3220,00066,40042,064Jan 10 05:34 PM
Quimi DaphneChief Financial OfficerJan 09Option Exercise2.7211,02230,007177,991Jan 10 05:27 PM
Campbell Bradley LChief Operating OfficerJan 09Option Exercise5.962,50014,900347,695Jan 10 05:28 PM
Quimi DaphneChief Financial OfficerJan 09Sale9.9315,000148,952166,969Jan 10 05:27 PM
MCGLYNN MARGARET GDirectorJan 09Sale10.0020,000200,00022,064Jan 10 05:34 PM
Campbell Bradley LChief Operating OfficerJan 09Sale10.012,50025,025345,195Jan 10 05:28 PM
Barth JayChief Medical OfficerJan 07Sale9.369,93892,980156,473Jan 08 07:46 PM
Barth JayChief Medical OfficerJan 06Sale9.286,83663,415166,411Jan 08 07:46 PM
Campbell Bradley LChief Operating OfficerJan 02Option Exercise5.967,50044,700366,640Jan 03 05:17 PM
Barth JayChief Medical OfficerJan 02Sale9.559,75393,173189,522Jan 03 05:21 PM
Rosenberg EllenChief Legal OfficerJan 02Sale9.5610,44899,884201,332Jan 03 05:20 PM
Campbell Bradley LChief Operating OfficerJan 02Sale9.5822,127211,889359,140Jan 03 05:17 PM
Crowley John FChairman & CEODec 16Option Exercise5.1320,000102,600755,694Dec 18 07:42 PM
Crowley John FChairman & CEODec 16Sale9.5520,000191,014735,694Dec 18 07:42 PM
Crowley John FChairman & CEODec 02Option Exercise3.8220,00076,400755,694Dec 04 05:17 PM
Crowley John FChairman & CEODec 02Sale10.3820,000207,618735,694Dec 04 05:17 PM
Crowley John FChairman & CEONov 25Option Exercise3.8240,000152,800775,694Nov 27 05:03 PM